Fact-checked by Grok 2 weeks ago

Hyperhidrosis

Hyperhidrosis is a medical condition characterized by abnormally excessive sweating that occurs beyond what is necessary for normal body temperature regulation, often without an obvious trigger such as heat or physical activity.^[1] It is classified into two main types: primary hyperhidrosis, which is focal and idiopathic, typically affecting areas like the palms, soles, underarms, or face due to overactive sympathetic nerve signals to eccrine sweat glands; and secondary hyperhidrosis, which is generalized or focal and results from an underlying medical condition, medication, or other systemic factor.^[2] The condition affects an estimated 4.8% of the population in the United States, or approximately 15.3 million individuals, with prevalence rates varying globally from approximately 0.07% to 16.3% depending on diagnostic criteria and study populations as reported in various studies up to 2023.^[3]^[4] Symptoms include visible perspiration that soaks through clothing or drips from the hands and feet, often occurring bilaterally and at least once a week while awake, and can lead to complications such as skin infections, emotional distress, social withdrawal, and impaired professional or educational functioning.^[1] Primary hyperhidrosis commonly begins in childhood or adolescence and has a genetic component, with 30% to 65% of affected individuals reporting a family history.^[2]^[5] The etiology of primary hyperhidrosis remains unclear but involves hyperactivity of the eccrine glands stimulated by cholinergic receptors, potentially linked to central nervous system dysregulation.^[2] In contrast, secondary hyperhidrosis is associated with conditions such as diabetes, hyperthyroidism, menopause, infections, neurological disorders, or medications like antidepressants and opioids, and may signal the need for evaluation of underlying health issues.^[6] Diagnosis typically involves a medical history, physical examination, and tests like the starch-iodine or gravimetric sweat tests to confirm excessive secretion and rule out secondary causes through blood work or imaging if necessary.^[6] Treatment options for hyperhidrosis are tailored to severity and type, starting with conservative measures such as prescription-strength antiperspirants containing aluminum chloride, followed by oral anticholinergics, iontophoresis, botulinum toxin injections, or surgical interventions like endoscopic thoracic sympathectomy for severe cases.^[1] While most individuals experience significant improvement with therapy, the condition can substantially impact quality of life, with nearly half of those affected reporting moderate to severe interference in daily activities.^[3]

Signs and symptoms

Characteristics of excessive sweating

Hyperhidrosis is defined as excessive sweating that surpasses the physiological requirements for thermoregulation, often occurring independently of environmental heat, physical activity, or emotional stimuli.^[1] This condition is typically focal in primary cases, affecting specific areas such as the palms, soles, axillae (underarms), or face, though generalized forms involving the entire body can occur in secondary hyperhidrosis.^[7] Quantitatively, focal hyperhidrosis is often assessed via gravimetric measurement, where thresholds vary by site and gender; for axillae, sweat production exceeding 50 mg over 5 minutes in women or 100 mg over 5 minutes in men indicates abnormality, while for palms it exceeds 30 mg/min, beyond normal rates that vary by site such as approximately 18 mg/min/m² for palms and 42 mg/min/m² for axillae.^[8]^[9]^[10] The sweating patterns in hyperhidrosis are characteristically bilateral and symmetric, distinguishing it from asymmetric perspiration seen in other conditions.^[11] It may manifest as episodic bursts or continuous secretion, with focal types frequently triggered by emotional stress or anxiety, while some episodes arise unprovoked even in cool, resting states. A key feature of primary hyperhidrosis is that sweating usually ceases during sleep, helping to differentiate it from secondary forms which may involve night sweats.^[1]^[12]^[13] Generalized patterns, in contrast, tend to involve diffuse sweating across larger body surfaces and are less responsive to specific triggers.^[14] Individuals with hyperhidrosis commonly experience noticeable physical manifestations, including drenched clothing or footwear that requires frequent changes, and dripping perspiration from affected sites.^[7] Prolonged wetness leads to skin maceration, where the epidermis becomes soft, wrinkled, or prone to cracking, increasing vulnerability to secondary issues.^[7] Additionally, the moist environment fosters bacterial proliferation on the skin, resulting in bromhidrosis—an unpleasant odor from the breakdown of sweat components by microorganisms.^[7]^[15] Onset of primary hyperhidrosis typically occurs during childhood or adolescence, often before age 25, and persists lifelong without remission in most cases.^[1]^[13] In secondary hyperhidrosis, symptoms emerge later in life, varying based on the underlying trigger, though the condition is classified separately from the idiopathic primary form.^[13]^[2]

Impact on daily life

Hyperhidrosis profoundly affects individuals' social interactions, often leading to significant stigma and embarrassment. Many patients experience shame due to visible sweating, which can result in avoidance of common social gestures such as handshakes or hugs, with 57% reporting difficulties in interpersonal exchanges and 75% actively avoiding public settings like parties or public transportation to evade judgment.^[16] This social withdrawal extends to broader isolation, where individuals may feel like outcasts, contributing to a pervasive sense of shame and reduced emotional well-being reported by 75% of affected people.^[17] In occupational settings, hyperhidrosis poses substantial challenges, particularly for tasks requiring manual dexterity or hygiene standards. Patients frequently struggle with gripping objects, turning doorknobs, writing, or using keyboards, with 63% indicating interference in work-related activities and 33% selecting career paths that accommodate their condition, such as avoiding roles in food handling or other hygiene-sensitive professions.^[16] These limitations can hinder productivity and professional confidence, as slippery hands complicate tool usage or equipment operation, leading some to expend extra time on compensatory measures like frequent hand drying.^[18] The psychological burden of hyperhidrosis is considerable, manifesting in elevated rates of anxiety and depression that impair overall quality of life. Anxiety affects 21.3% of patients compared to 7.5% in the general population, while depression impacts 27.2% versus 9.7%, with 69% experiencing negative emotions such as constant worry and embarrassment.^[17] Dermatology Life Quality Index (DLQI) scores for those with axillary or palmar hyperhidrosis often range from 8.8 to 15, indicating moderate to severe impairment, and 50% report feeling their life is restricted by the condition.^[16] Specific daily interferences further compound these effects, including challenges in romantic relationships where sweating undermines confidence and intimacy, prompting avoidance of dating scenarios. Participation in sports is similarly disrupted, especially in activities demanding a firm grip like gymnastics or tennis, causing embarrassment and anxiety that deter involvement. Clothing choices are restricted, with 61% avoiding bright colors or synthetic fabrics to conceal sweat stains, limiting personal expression and comfort.^[16]^[19]

Classification

Primary hyperhidrosis

Primary hyperhidrosis, also known as focal or essential hyperhidrosis, is defined as excessive sweating confined to specific areas of the body, occurring beyond the physiological requirements for thermoregulation and without an identifiable underlying systemic cause.^[2] This condition manifests as focal, bilateral, and symmetric perspiration, distinguishing it from generalized forms, and is driven by overactivity in the eccrine sweat glands rather than external factors like heat or exercise.^[20] The sweating episodes are typically unpredictable and can interfere with daily activities, but they do not occur during sleep, which helps differentiate it from other disorders.^[2] The most commonly affected sites include the palms (palmar hyperhidrosis), soles (plantar hyperhidrosis), axillae (axillary hyperhidrosis), and craniofacial region, where eccrine gland density is highest.^[2] These areas experience profuse sweating that is often visible and may lead to secondary issues like skin maceration or odor, though the primary pathology remains idiopathic.^[20] Primary hyperhidrosis is frequently genetic in origin, with a family history present in 30-50% of cases and inheritance typically following an autosomal dominant pattern with incomplete penetrance.^[21]^[22] Onset of symptoms usually occurs early in life, most commonly before the age of 25, and the condition tends to persist lifelong without spontaneous resolution.^[2] This early and enduring presentation underscores its idiopathic nature, as opposed to acquired forms. Diagnosis hinges on clinical history and physical examination, with key exclusion criteria including the absence of secondary precipitants such as fever, medications, neurological conditions, or endocrine imbalances that could induce sweating.^[2] No nocturnal sweating or unilateral involvement should be present, as these suggest alternative etiologies.^[20] The underlying mechanism involves dysregulated sympathetic cholinergic stimulation of eccrine glands, leading to focal overproduction of sweat.^[2]

Secondary hyperhidrosis

Secondary hyperhidrosis refers to excessive sweating that arises as a consequence of an identifiable underlying medical condition, medication, or external factor, distinguishing it from the idiopathic, focal nature of primary hyperhidrosis. Unlike primary hyperhidrosis, which typically involves symmetric sweating in specific areas without an apparent cause, secondary hyperhidrosis is often acquired and systemic, manifesting as generalized sweating across the body or in focal regions due to pathology, and it may present asymmetrically or predominantly at night. Symptoms typically begin after the age of 25 years, often in adulthood.^[2]^[23]^[24]^[25] This form of hyperhidrosis is frequently associated with systemic illnesses, where sweating serves as a symptom of broader disease processes. For instance, night sweats are a common feature in infections such as tuberculosis or malignancies like lymphoma, often occurring alongside other constitutional symptoms like fever or weight loss. These associations highlight how secondary hyperhidrosis can signal serious underlying conditions that require prompt medical attention.^[26]^[27]^[28] Key categories of secondary hyperhidrosis encompass disorders affecting various physiological systems, including endocrine conditions such as hyperthyroidism, which can lead to increased metabolic activity and sweating; neurologic disorders like Parkinson's disease, involving dysregulation of autonomic functions; as well as infections, malignancies, and medication side effects. These categories provide a framework for understanding the diverse etiologies, though the specific presentation varies by the underlying pathology.^[24]^[23]^[2] The diagnostic implication of secondary hyperhidrosis is significant, as it underscores the need for comprehensive investigation to uncover and address treatable causes, potentially improving outcomes by targeting the root pathology rather than symptoms alone. Clinicians typically pursue a detailed history, physical examination, and targeted tests to differentiate it from primary forms and identify reversible factors.^[24]^[27]^[2]

Pathophysiology

Normal sweat production

Human skin contains two primary types of sweat glands: eccrine and apocrine, each with distinct anatomical distributions and functions. Eccrine glands, numbering approximately 2 to 4 million, are widely distributed across nearly the entire body surface, with the highest densities on the palms (up to 620 per cm²), soles, and forehead. These glands consist of a coiled secretory portion in the dermis and a duct that opens directly onto the skin surface, enabling the production of a clear, watery fluid essential for thermoregulation. They are innervated by postganglionic sympathetic cholinergic fibers that release acetylcholine to stimulate secretion.^[29]^[30]^[31] Apocrine glands, in contrast, are far fewer and confined to specific regions such as the axillae, anogenital area, and areolae. Larger than eccrine glands, they feature a wider duct that opens into hair follicles rather than directly onto the skin, secreting a thicker, milky fluid rich in lipids and proteins that can become odorous through bacterial action. While primarily responsive to emotional and stress-related stimuli, apocrine glands contribute minimally to overall sweat volume compared to eccrine glands.^[30]^[32]^[33] Sweat production is primarily regulated by the sympathetic nervous system, which differentiates between thermoregulatory and emotional sweating. Thermoregulatory sweating, triggered by elevated core temperature from environmental heat or physical exercise, promotes evaporative cooling to maintain homeostasis and is mediated through hypothalamic integration with spinal sympathetic outflow, ultimately releasing acetylcholine at the eccrine gland level. Emotional sweating, activated by psychological factors like anxiety or stress, is more localized to glabrous skin areas such as the palms, soles, and axillae, yet follows a similar cholinergic pathway. This dual regulation ensures adaptive responses to both physiological and environmental demands.^[34]^[35]^[36] In healthy individuals, eccrine glands produce up to 0.5 to 1 liter of sweat per hour at maximum capacity during intense exertion, though rates vary based on factors like fitness level, acclimatization, and ambient conditions; this output is typically sufficient for thermoregulation without excessive fluid loss. Production remains localized and proportional to stimuli, with thermoregulatory sweating distributed broadly across the body and emotional sweating confined to specific sites. Hormonal modulation, including a minor role for adrenaline (epinephrine) in amplifying stress-induced responses via beta-adrenergic receptors on apocrine and some eccrine glands, supplements but does not dominate the primary neural control.^[37]^[38]^[39]

Dysregulated mechanisms

In hyperhidrosis, the primary dysregulated mechanism involves overactive cholinergic signaling, where eccrine sweat glands exhibit hypersensitivity to acetylcholine, the neurotransmitter responsible for stimulating sweat secretion. This overstimulation occurs through excessive activation of muscarinic cholinergic receptors on the eccrine glands, leading to profuse sweating disproportionate to thermoregulatory needs.^[2] In particular, upregulation of the cholinergic receptor nicotinic alpha 1 subunit (CHRNA1) in eccrine glands has been implicated in primary focal hyperhidrosis, enhancing glandular responsiveness to neural impulses.^[40] Sympathetic hyperactivity further contributes to this dysregulation, manifesting as overdrive in the central or peripheral nervous system that amplifies sweat gland activation. In primary hyperhidrosis, this may stem from a central nervous dysfunction in the hypothalamus or aberrant peripheral signaling, resulting in abnormal sweat secretion without external triggers.^[12] Genetic factors have been investigated, with animal model studies suggesting involvement of the aquaporin-5 (AQP5) gene, which facilitates water transport in sweat glands; however, human studies show no significant expression differences, and its role in primary hyperhidrosis remains unclear.^[22] For secondary hyperhidrosis, alterations include metabolic changes that disrupt normal thermoregulation; for instance, during menopause, estrogen withdrawal leads to instability in the hypothalamic thermoregulatory center, causing episodic surges in sympathetic outflow and excessive sweating akin to hot flashes.^[41] Research utilizing thermography and biopsy has confirmed elevated sweat gland activity in hyperhidrosis. Infrared thermography reveals rapid skin cooling due to accelerated evaporation from high sweat output, providing a noninvasive measure of glandular hyperactivity.^[42] Biopsies typically show morphologically normal eccrine glands in terms of size and density, underscoring that the disorder arises from functional overactivity rather than structural proliferation, with sweat production in affected areas reaching up to 10 times the normal rate.^[2]^[5]

Causes

Primary causes

Primary hyperhidrosis is characterized by excessive sweating without an underlying medical condition or identifiable external trigger, distinguishing it from secondary forms. The etiology remains largely idiopathic, with research pointing to innate factors such as genetic and neural influences that lead to overactive sweat production in focal areas like the palms, soles, axillae, and craniofacial region.^[2] A significant genetic predisposition is evident, as approximately 35-65% of individuals with primary hyperhidrosis report a positive family history, indicating a hereditary component with potential autosomal dominant inheritance and variable penetrance.^[5] Genome-wide linkage studies have identified a susceptibility locus for primary palmar hyperhidrosis on chromosome 14q11.2-q13, particularly in families of Asian descent, though replication across populations has been inconsistent.^[43] More recent genome-wide association studies (GWAS) have associated the condition with single nucleotide polymorphisms (SNPs) in genes on chromosomes 2 and 16, potentially influencing sweat gland function, though specific sweat gland receptor variants require further validation.^[22] Neural factors play a central role, involving focal overactivity of the sympathetic nervous system that innervates eccrine sweat glands in affected areas, independent of thermoregulatory or emotional stimuli.^[12] This overactivity may stem from developmental abnormalities in sympathetic innervation, such as aberrant nerve regeneration or hypersensitivity of postganglionic cholinergic fibers, leading to exaggerated acetylcholine release and sweat secretion.^[44] Unlike emotional sweating, which is triggered by stress or anxiety via higher cortical centers, primary hyperhidrosis occurs spontaneously or with minimal provocation, suggesting a localized dysregulation rather than generalized autonomic imbalance.^[45] Hypothesized minor central nervous system anomalies, such as subtle disruptions in hypothalamic or cortical control of sudomotor pathways, may contribute to this focal pattern, though direct evidence remains limited.^[12] Dysregulated cholinergic pathways in the peripheral nerves amplify this neural hypersensitivity.^[2]

Secondary causes

Secondary hyperhidrosis arises from identifiable underlying medical conditions that disrupt normal thermoregulatory or autonomic mechanisms, leading to excessive sweating that is often generalized and may occur at night.^[2]

Endocrine Disorders

Endocrine conditions frequently contribute to secondary hyperhidrosis by altering metabolic rates or hormonal balance, resulting in heightened sympathetic activity and sweat gland stimulation. Hyperthyroidism, characterized by overproduction of thyroid hormones, commonly presents with generalized sweating due to increased basal metabolic rate.^[28] Diabetes mellitus can induce hyperhidrosis through autonomic neuropathy, which impairs nerve signals to sweat glands and may cause compensatory excessive sweating, particularly gustatory sweating after meals.^[14] Acromegaly, caused by excess growth hormone from a pituitary adenoma, leads to profuse sweating as a result of tissue overgrowth and metabolic changes.^[28] Menopause often triggers episodic hyperhidrosis in the form of hot flashes and night sweats due to fluctuating estrogen levels affecting hypothalamic thermoregulation.^[28]

Neurologic Disorders

Neurologic conditions can cause secondary hyperhidrosis by damaging central or peripheral autonomic pathways, leading to dysregulated sweat production that may be focal or asymmetric. Stroke may result in unilateral or hemibody sweating due to disruption of brainstem or cortical centers controlling sympathetic outflow.^[23] Spinal cord injuries often produce abnormal sweating patterns below the lesion level, such as anhidrosis above and hyperhidrosis below, stemming from interrupted spinal sympathetic tracts.^[46] Parkinson's disease is associated with hyperhidrosis through central autonomic failure, exacerbating motor symptoms with episodes of drenching sweats.^[47] Peripheral neuropathies, including those from diabetes or other etiologies, can lead to focal hyperhidrosis by altering sensory and autonomic nerve function in affected areas.^[14]

Infectious Diseases

Infections can provoke secondary hyperhidrosis as part of systemic inflammatory responses or fever mechanisms, often manifesting as night sweats. Tuberculosis frequently causes drenching night sweats due to cytokine release and nocturnal fever spikes in active pulmonary or extrapulmonary disease.^[28] HIV infection, particularly in advanced stages or with opportunistic infections, is linked to hyperhidrosis through immune dysregulation and associated fevers.^[2] Endocarditis may induce profuse sweating, especially at night, as a constitutional symptom accompanying bacteremia and fever.^[28]

Other Causes

Malignancies such as lymphoma can cause secondary hyperhidrosis via paraneoplastic syndromes, cytokine-mediated effects, or direct tumor invasion of autonomic structures, commonly presenting as night sweats.^[28] Certain medications, including antidepressants like selective serotonin reuptake inhibitors (SSRIs) and opioids, induce hyperhidrosis by modulating central thermoregulatory centers or cholinergic pathways.^[48] Metabolic disturbances, such as hypoglycemia in diabetic patients, trigger adrenergic responses that manifest as acute sweating episodes.^[28] Recent studies from 2024-2025 have highlighted emerging associations between post-COVID-19 autonomic dysfunction and hyperhidrosis, where persistent sympathetic overactivity post-infection leads to excessive sweating as part of long COVID symptoms.^[49]

Diagnosis

Clinical assessment

The clinical assessment of hyperhidrosis begins with a thorough patient history to characterize the condition and differentiate primary from secondary forms. Key elements include the age of onset, which is typically during childhood or adolescence for primary hyperhidrosis, and the specific sites affected, such as the axillae, palms, soles, or craniofacial areas in focal cases, or generalized distribution in secondary cases.^[50] Patients are questioned about triggers, including emotional stress, heat, or physical activity, noting that sweating in primary hyperhidrosis often occurs symmetrically and independently of thermoregulation needs.^[51] Family history is elicited, as primary hyperhidrosis has a genetic component in up to 65% of cases.^[5] The impact on daily life is assessed, encompassing social embarrassment, occupational limitations, and psychological effects like anxiety.^[52] Physical examination involves direct observation of sweating, often provoked by placing the patient in a warm environment or using exercise to elicit visible perspiration in affected areas.^[50] Inspection may reveal skin changes such as maceration, fissuring, or hyperkeratosis on the palms and soles due to chronic moisture, along with potential secondary complications like bacterial or fungal infections.^[51] The examination also evaluates for asymmetry or unilateral involvement, which may suggest underlying neurologic issues, and assesses overall body habitus, such as obesity, which can exacerbate symptoms.^[52] To exclude secondary hyperhidrosis, clinicians screen for systemic symptoms in the history, including unexplained weight loss, night sweats, fever, fatigue, or symptoms suggestive of endocrine, infectious, or neoplastic disorders, as well as medication use or recent changes in health status.^[5] The absence of such red flags supports a primary diagnosis, while their presence warrants further investigation.^[50] Severity is graded using the Hyperhidrosis Disease Severity Scale (HDSS), a validated single-item questionnaire that evaluates the tolerability of sweating and its interference with daily activities on a 4-point scale: grade 1 (tolerable sweating that never bothers the patient), grade 2 (tolerable but sometimes interferes with activities), grade 3 (barely tolerable and frequently interferes), and grade 4 (intolerable and always interferes).^[53] This tool provides a qualitative measure to guide management, with grades 3 and 4 indicating moderate to severe disease that significantly disrupts quality of life.^[52]

Diagnostic tests

Diagnostic tests for hyperhidrosis provide objective verification of excessive sweating, helping to quantify severity and distinguish primary from secondary forms by evaluating sweat production patterns and excluding underlying conditions.^[2] These methods are typically employed after clinical assessment to confirm the diagnosis and guide treatment planning.^[10] The starch-iodine test is a simple, qualitative method to visualize areas of excessive sweating. It involves applying a 2% iodine solution to the affected skin, followed by a starch powder or solution; in the presence of sweat, the mixture turns dark blue or purple, delineating the hyperhidrotic regions.^[54]^[13]^[10] This test is particularly useful for mapping focal sweating in areas like the palms, axillae, or soles prior to interventions such as botulinum toxin injections.^[55] Gravimetric measurement offers a quantitative assessment by weighing absorbed sweat over a fixed time period. Filter paper or absorbent material is placed on the skin (e.g., palms or axillae) for 5-10 minutes, then weighed to calculate sweat rate in milligrams per minute; rates exceeding 20 mg/min for axillae in men or 10 mg/min in women, and 30-40 mg/min for palms, support a diagnosis of hyperhidrosis.^[10]^[13] This technique provides baseline data for monitoring treatment efficacy but requires controlled conditions to ensure accuracy.^[56] The thermoregulatory sweat test evaluates overall sweat distribution and function by exposing the body to controlled heat and humidity, typically in a chamber, while using an indicator like iodine-starch or alizarin red dye to map sweating patterns on the skin.^[54]^[57] It reveals asymmetries or anhidrotic areas that may indicate neurological involvement, aiding in differentiating primary hyperhidrosis from conditions with dysregulated thermoregulation.^[58] Recent advancements include quantitative sudometry, which uses electrochemical sensors or digital imaging to precisely measure sweat droplet formation and rate in real-time, offering higher sensitivity for focal hyperhidrosis assessment.^[5]^[59] Infrared thermography, a non-invasive imaging technique, detects hyperhidrosis by capturing temperature variations on the skin surface caused by evaporative cooling from sweat, with cooler areas indicating excessive perspiration; it has shown utility in diagnosing palmar hyperhidrosis and monitoring post-treatment changes.^[60]^[61] To rule out secondary hyperhidrosis, laboratory tests such as thyroid-stimulating hormone (TSH) levels for hyperthyroidism or fasting glucose for diabetes are performed, as abnormalities may indicate an underlying systemic cause.^[54]^[2] These tests are essential when sweating is generalized or accompanied by other symptoms.^[13]

Treatment

Topical and conservative therapies

Topical and conservative therapies represent the initial approach to managing hyperhidrosis, focusing on non-invasive methods to reduce sweat production locally or through behavioral adjustments, particularly for primary focal symptoms affecting areas like the axillae, palms, soles, and craniofacial regions. These treatments are generally safe, cost-effective, and suitable for mild to moderate cases, with efficacy varying by site and patient adherence. They aim to either physically obstruct sweat glands or mitigate triggers without systemic effects. Antiperspirants containing aluminum chloride hexahydrate at concentrations of 20-25%, such as Drysol, are considered first-line topical agents for controlling excessive sweating. These formulations work by forming insoluble aluminum salts that precipitate within the eccrine sweat gland ducts, creating a temporary plug that blocks sweat secretion.^[62] For optimal results, they should be applied to completely dry skin at bedtime, allowing several hours without washing, and used nightly initially, then reduced to 2-3 times per week as symptoms improve; irritation can be minimized by starting with lower strengths and using emollients.^[63] Clinical studies demonstrate significant sweat reduction, with up to 60-80% improvement in axillary hyperhidrosis after consistent use.^[64] Iontophoresis involves passing a mild electrical current through water-soaked skin to inhibit sweat gland activity, typically using tap water or solutions like glycopyrrolate for enhanced efficacy, and is particularly effective for palmar and plantar hyperhidrosis. Sessions last 15-30 minutes at 10-20 mA, conducted 2-3 times per week initially until dryness is achieved, followed by maintenance every 1-4 weeks.^[65] Glycopyrrolate-augmented iontophoresis delivers the anticholinergic agent transdermally, providing superior results over tap water alone, with minimal side effects like transient tingling.^[66] Efficacy reaches approximately 80% symptom improvement for hands and feet, with sustained benefits in most patients upon adherence.^[67] Conservative lifestyle measures complement topical treatments by addressing environmental and dietary triggers that exacerbate sweating. Patients are advised to wear loose, absorbent clothing made from natural fibers like cotton to promote evaporation and reduce moisture retention, while avoiding synthetic fabrics or tight garments.^[68] Dietary adjustments, such as limiting spicy foods, caffeine, and alcohol, can help minimize sudomotor stimulation, as these substances increase cholinergic activity in sweat glands.^[47] Topical anticholinergic wipes, such as those containing glycopyrronium tosylate (e.g., Qbrexza), offer a convenient alternative for axillary control by blocking acetylcholine receptors at sweat glands, applied once daily with reported reductions in sweat production by over 50% in clinical use.^[54] In 2024, the U.S. Food and Drug Administration approved sofpironium bromide 12.45% topical gel (Sofdra) as the first new chemical entity for treating primary axillary hyperhidrosis in adults and children aged 9 years and older. This anticholinergic agent inhibits muscarinic receptors to reduce eccrine sweat production when applied once daily to the underarms, with phase 3 trials showing significant gravimetric sweat reduction (about 50-60%) and improved quality of life compared to vehicle.^[69] Common side effects include mild application-site dryness and urinary hesitation, but systemic absorption is minimal due to its soft-drug design.^[70]

Systemic and procedural therapies

Systemic therapies for hyperhidrosis primarily involve oral anticholinergics, which inhibit muscarinic receptors to reduce cholinergic overactivity and suppress sweat production across the body. Glycopyrrolate, a quaternary ammonium compound with limited central nervous system penetration, is administered at doses of 1-2 mg twice daily (BID) for moderate to severe cases, showing efficacy in reducing sweating in approximately 74% of patients.^[71] Oxybutynin, another anticholinergic, is typically dosed starting at 2.5 mg daily and titrated up to 5-10 mg daily in divided doses, providing symptomatic relief in 60-97% of patients with primary hyperhidrosis.^[72] However, these agents are associated with anticholinergic side effects, including dry mouth (reported in 70-100% of users), constipation, blurred vision, and urinary retention, which contribute to discontinuation rates of up to 26-50% due to tolerability issues.^[73]^[74] Procedural therapies offer targeted, minimally invasive options for localized hyperhidrosis, particularly when systemic treatments are insufficient. Botulinum toxin type A (onabotulinumtoxinA) is injected intradermally into affected areas, with 50-100 units per axilla recommended to block acetylcholine release at sweat glands, achieving 80-90% reduction in sweating.^[75] Approved by the FDA in 2004 for primary axillary hyperhidrosis, its effects last 4-12 months, with repeat injections required for maintenance.^[76]^[77] The procedure costs approximately $1,000 per session for both axillae, though insurance coverage varies.^[78] Microwave thermolysis, such as the miraDry system, uses non-invasive microwave energy to selectively heat and destroy eccrine sweat glands in the axillae while sparing surrounding tissues. A single or two-session protocol delivers an average 82% reduction in sweat production, with 90% of patients achieving at least 50% improvement at 12 months post-treatment.^[79]^[80] This FDA-cleared procedure provides durable results, often permanent, with common transient side effects including swelling and numbness.^[81] As of 2025, emerging procedural options include laser therapies, such as image-guided Nd:YAG or fractional CO2 lasers, which ablate sweat glands with minimal downtime and show promise in pilot studies for axillary hyperhidrosis.^[82] Topical botulinum toxin formulations, like liposomal creams, are under development to enable non-injective delivery, demonstrating sweat reduction comparable to injections in early trials without needles.^[83]

Surgical interventions

Surgical interventions for hyperhidrosis are reserved for severe, refractory cases of primary hyperhidrosis, particularly involving the palms and axillae, where conservative and procedural therapies have failed to provide adequate relief. These procedures aim to permanently disrupt sweat gland activity or sympathetic nerve signaling but carry significant risks, including compensatory sweating and potential irreversibility. Indications typically include patients with debilitating symptoms impacting quality of life, after exhaustive trials of topical agents, iontophoresis, and botulinum toxin injections. Endoscopic thoracic sympathectomy (ETS) is the primary surgical option for palmar and axillary hyperhidrosis, involving video-assisted interruption of the thoracic sympathetic chain, most commonly at the T2-T4 ganglia levels using clips or cautery to block nerve signals to sweat glands. This minimally invasive procedure achieves initial success rates of 85-95% in eliminating targeted hyperhidrosis, with long-term efficacy reported at 94.5% for palmar and axillary sites in follow-up studies exceeding a decade. However, compensatory sweating in untreated areas, such as the trunk and legs, occurs in approximately 60% of cases, ranging from mild to severe and often diminishing over time but remaining a leading cause of dissatisfaction. Reversible clips are preferred over permanent ablation to allow potential reversal via clip removal, with reversal requested in up to 10% of cases due to severe compensatory sweating. For localized axillary hyperhidrosis, local excision techniques such as curettage or tumescent liposuction target eccrine and apocrine sweat glands directly through small incisions, scraping or aspirating glandular tissue while preserving skin integrity. These methods yield satisfaction rates of 80-90%, with excellent sweat reduction in up to 90% of treated axillae and lower complication profiles compared to more extensive excisions, including minimal scarring and rare infections. Liposuction-curettage is particularly favored for its outpatient feasibility and equivalence in efficacy to alternative surgical approaches, though recurrence may occur in 10-20% of cases over 5 years.

Prognosis

Disease course

Primary hyperhidrosis is a chronic condition that typically emerges during childhood or adolescence and persists lifelong, affecting specific focal areas without an identifiable medical cause. In contrast, secondary hyperhidrosis arises from an underlying medical condition, such as endocrine disorders, infections, or medications, and often resolves completely once the root cause is effectively treated.^[1]^[84]^[85] The condition follows an episodic pattern, with sweating generally stable during routine activities but flaring in response to emotional stressors like anxiety or social situations, as well as environmental triggers such as heat or humidity. These exacerbations can intensify the impact on daily functioning, though the baseline severity remains consistent over time absent such provocations.^[1]^[86]^[87] A multimodal treatment strategy, combining topical agents, systemic medications, and procedural interventions, enables many patients to achieve satisfactory symptom control, though long-term management is often required due to the chronic nature of primary hyperhidrosis. Relapse is particularly common after botulinum toxin injections, with effects typically lasting 4 to 12 months before sweating recurs, necessitating repeat treatments for sustained relief.^[88]^[89] For secondary hyperhidrosis, ongoing monitoring through annual clinical reassessment is essential to detect any evolution of the underlying condition, such as emerging endocrine abnormalities, ensuring timely intervention to prevent progression.^[1]^[90]

Complications

Untreated hyperhidrosis predisposes individuals to various skin complications due to the persistently moist environment created by excessive sweating. Maceration, characterized by the skin becoming soft, white, and wrinkled from prolonged moisture exposure, is common and can lead to breakdown, cracks, or fissures that facilitate secondary infections.^[13] Fungal infections, such as tinea pedis and tinea cruris, thrive in these conditions, often presenting with scaling, itching, and further maceration, while bacterial infections may cause dermatitis or cellulitis.^[44] In severe or prolonged cases, maceration and infections can contribute to chronic non-healing wounds or ulcers, particularly in areas like the feet or intertriginous regions.^[91] Psychological complications are significant, with primary hyperhidrosis linked to elevated rates of anxiety disorders and social phobia. Studies report anxiety prevalence among affected individuals ranging from 17.6% to 49.6%, often exacerbated by avoidance behaviors and reduced self-efficacy stemming from fear of visible sweating.^[92] Depression affects 11.2% to 60% of patients, with odds ratios indicating a substantially higher risk compared to controls or those with other dermatological conditions.^[92] Excessive sweating is also a frequent symptom in social anxiety disorder, further compounding interpersonal distress.^[93] In rare severe cases, the condition's impact on daily life has been associated with suicidal ideation. Treatment-related complications add further challenges. Surgical options like endoscopic thoracic sympathectomy carry a risk of compensatory hyperhidrosis, where sweating intensifies in untreated areas such as the trunk or legs, affecting approximately 50% to 80% of patients depending on the procedure level.^[94] Anticholinergic therapies, including oral oxybutynin or topical glycopyrrolate, commonly cause side effects like constipation, blurred vision, dry mouth, and urinary retention due to their systemic effects on cholinergic receptors.^[2]

Epidemiology

Prevalence and incidence

Hyperhidrosis affects an estimated 0.6–16.7% of the global population, with prevalence rates varying widely across studies due to differences in diagnostic criteria and self-reporting.^[95] Primary hyperhidrosis, which accounts for the majority of cases (approximately 93% as of 2025) and is not caused by an underlying medical condition, has an estimated prevalence of approximately 1–5%.^[3]^[96] In contrast, reported rates can reach up to 20% in some populations when including both primary and secondary forms.^[3] Prevalence appears higher in certain regions, particularly in Asia, where studies indicate rates of up to 12.8% in Japan and 14.5% in Shanghai, potentially due to genetic factors and environmental influences.^[3]^[97] Geographic variation also shows elevated occurrence in tropical and subtropical climates, where excessive sweating may be more common or frequently misattributed to normal thermoregulation rather than a disorder.^[98] The condition typically manifests during adolescence or early adulthood, with onset most commonly between ages 14 and 25, and incidence peaking in those under 30 years, after which rates decline significantly. Incidence data are limited, but symptoms often become more noticeable and disruptive in this age group. Despite its impact, hyperhidrosis remains underdiagnosed, with only about 40–51% of affected individuals seeking medical care, often after years of delay.^[99]^[100] As of 2025, epidemiological forecasts suggest stable overall prevalence, though rising awareness and improved diagnostics are leading to increased reported cases worldwide.^[98]

Risk factors and demographics

Hyperhidrosis exhibits distinct demographic patterns, with primary focal hyperhidrosis typically onsetting during adolescence or early adulthood, most commonly between the ages of 14 and 25 years, and showing the highest prevalence among individuals younger than 30 years, after which rates decline significantly.^[101] The condition affects males and females equally in terms of prevalence, though women may be overrepresented in clinical records due to higher rates of seeking medical care.^[102] Regarding ethnicity, Caucasians experience at least 2.5 times higher prevalence of primary hyperhidrosis compared to Chinese populations, while Japanese populations report rates over 20 times higher than other ethnicities for palmoplantar forms; additional ethnic predispositions include elevated rates among Jews of North African or Yemeni descent.^[101]^[44]^[4] Key risk factors for primary hyperhidrosis center on genetics, with a strong hereditary component evidenced by autosomal dominant inheritance patterns featuring variable penetrance and no sex-linked transmission; 30–65% of affected individuals report a positive family history, substantially elevating risk among first-degree relatives such as parents or siblings.^[103]^[104] In contrast, secondary hyperhidrosis arises from identifiable triggers, including underlying medical conditions or medications (see Causes). No definitive environmental or lifestyle risk factors have been consistently linked to primary hyperhidrosis beyond genetic predisposition.^[2]

References

[1]
Hyperhidrosis - Symptoms and causes - Mayo Clinic
Oct 25, 2024 · Hyperhidrosis treatment usually helps. It often begins with antiperspirants. If these don't help, you may need to try different medications and ...
[2]
Hyperhidrosis - StatPearls - NCBI Bookshelf - NIH
Oct 3, 2022 · Hyperhidrosis is a disorder of excessive sweating due to the overstimulation of cholinergic receptors on eccrine glands.Introduction · Etiology · History and Physical · Treatment / Management
[3]
Hyperhidrosis: an update on prevalence and severity in the United ...
Oct 15, 2016 · Current results estimate the prevalence of hyperhidrosis at 4.8 %, which represents approximately 15.3 million people in the United States.
[4]
Hyperhidrosis: MedlinePlus Medical Encyclopedia
### Summary of Hyperhidrosis (https://medlineplus.gov/ency/article/007259.htm)
[5]
Hyperhidrosis: Signs and symptoms
Jul 16, 2024 · If the area(s) from which you sweat is frequently wet, you can develop an unpleasant body odor. This odor occurs when sweat mixes with bacteria ...Missing: sensory | Show results with:sensory
[6]
Primary Hyperhidrosis in Children—A Retrospective Study and a ...
May 19, 2024 · Axillary hyperhidrosis is diagnosed at sweat values over 100 mg/5 min/axillae for men and 50 mg/5 min/axillae for women [4,32,33,34].
[7]
Gravimetry in sweating assessment in primary hyperhidrosis and ...
In healthy volunteers, mean value of gravimetrically evaluated intensity of sweating were: facial: 19.15 ± 14.97 mg/min/m2, palmar: 18.49 ± 14.06 mg/min/m2, ...
[8]
Hyperhidrosis Prevalence: A Disease Underreported by Patients ...
Nov 1, 2019 · The overall prevalence of HH was 17.9% (149/832), whereas only self-reported prevalence was 10.2% (85/832) in the dermatology outpatients.
[9]
Hyperhidrosis: A Central Nervous Dysfunction of Sweat Secretion
Hyperhidrosis (HH) is a central nervous dysfunction characterized by abnormally increased sweating due to a central dysregulation of sweat secretion.
[10]
Hyperhidrosis—Causes and Treatment of Enhanced Sweating - PMC
Jan 16, 2009 · Enhanced sweating, called hyperhidrosis, can be generalized or focal. Primary focal hyperhidrosis is the most common type and affects the axillae, hands, feet, ...
[11]
The Effects on Patients' Lives: Physical Discomfort
Skin maceration from constant wetness can lead to bacterial and fungal overgrowth. This overgrowth can then lead to intertrigo, bromhidrosis (foul-smelling ...Missing: sensory | Show results with:sensory
[12]
Hyperhidrosis: Types, Causes, Symptoms & Treatment
Hyperhidrosis is excessive sweating. It's the result of overactive sweat glands. Treatments are available to help you manage this common condition.Missing: unprovoked | Show results with:unprovoked
[13]
https://my.clevelandclinic.org/health/diseases/17113-hyperhidrosis
[14]
Hyperhidrosis & Mental Health Impact | Official Site
rates significantly higher than those reported in the ...
[15]
Occupational Tasks and Activities of Daily Living
The majority of respondents said hyperhidrosis interferes with general tasks like holding objects, turning door handles, opening jars, working with tools, ...Missing: hygiene | Show results with:hygiene
[16]
Pediatric Sports Dermatology | Pediatrics In Review - AAP Publications
May 1, 2024 · Hyperhidrosis can cause significant anxiety, embarrassment, and disruption for athletes, especially for those sports requiring a dry grip.
[17]
Primary hyperhidrosis: an updated review - PMC - PubMed Central
Hyperhidrosis (HH) is a condition characterized by excessive sweating beyond the physiological needs of thermoregulation. HH can be classified as primary ...
[18]
An epidemiological study of hyperhidrosis patients visiting the
Apr 16, 2010 · Stolman suggested a genetic predisposition may exist, since 30-50 ... Primary hyperhidrosis-evidence for autosomal dominant inheritance.
[19]
Primary hyperhidrosis: From a genetics point of view - PMC
Dec 21, 2023 · Primary hyperhidrosis is a disorder of profuse sweating which negatively influences a patient's quality of life and is caused because of ...
[20]
Hyperhidrosis - Dermatologic Disorders - Merck Manuals
Sweating of the axillae, palms, and soles is most often a normal response due to stress, exercise, or environmental heat; diffuse sweating is usually idiopathic ...Missing: unprovoked | Show results with:unprovoked
[21]
Evaluation of the patient with night sweats or generalized ...
Aug 29, 2024 · DIFFERENTIAL DIAGNOSIS · Infections · Malignancies · Medications · Endocrine causes · Neurologic causes · Sleep disorders · Other causes.
[22]
Causes of Secondary Hyperhidrosis
Endocrine disorders associated with hyperhidrosis ... Night sweats can be associated with tuberculosis, endocarditis, other chronic infections, lymphoma ...Missing: diagnostic | Show results with:diagnostic
[23]
Full article: When to investigate for secondary hyperhidrosis
Jul 29, 2022 · Excessive sweating has been reported in association with numerous diseases, including tuberculosis, lymphoma ... Persistent night sweats: ...
[24]
Excessive sweating Causes - Mayo Clinic
It happens when excess sweating is not triggered by a rise in temperature or physical activity. Primary hyperhidrosis may be at least partly hereditary.Acromegaly · Diabetic hypoglycemia · Hyperthyroidism (overactive... · Lymphoma
[25]
What Are Eccrine Glands? - Cleveland Clinic
Aug 15, 2025 · You have anywhere from 2 million to 4 million eccrine sweat glands. The exact number can vary widely from person to person. Where are eccrine ...
[26]
Anatomy, Skin Sweat Glands - StatPearls - NCBI Bookshelf
Sweat glands are appendages of the integument. There are eccrine and apocrine sweat glands. They differ in embryology, distribution, and function.
[27]
Eccrine Sweat Gland - an overview | ScienceDirect Topics
Eccrine sweat glands (2–4 million) are present over the entire body surface but are most numerous over the soles (620 ± 20 cm−2), the forehead and axillae (360 ...
[28]
Structure and function of the sweat glands - Kenhub
Eccrine glands are found all over the body and secrete a watery product that cools the skin. · Apocrine sweat glands are mainly found in the armpits and perianal ...
[29]
Apocrine Glands Function & Location - Cleveland Clinic
Aug 22, 2024 · Apocrine sweat glands are located mostly in your armpits and genital area. They secrete oily sweat that doesn't have a clear function. While not ...
[30]
Sweat Gland Function - an overview | ScienceDirect Topics
In normal eccrine gland physiology, the volume and rate of sweat production vary depending on thermoregulatory requirements. In addition, emotional and ...
[31]
Neural control of sweat secretion: a review - PubMed
Acetylcholine acts as a potent stimulator for sweat secretion, which is released by sympathetic nerves. β-adrenoceptors are found in adipocytes as well as ...
[32]
Full article: Physiology of sweat gland function: The roles of ...
Regional sweat [Na] typically ranges from 10 to 90 mmol/L ( Figure 5(a ); see also [Citation144–Citation148]), while whole-body sweat [Na] is ~20–80 mmol/L ( ...
[33]
Why athletes need to know how much they sweat - UCLA Health
A typical sweat rate for a healthy, average-sized person hovers around the 500 mL per hour range. That number tells you what rate you should be hydrating at.
[34]
How Much Does an Average Person Sweat in a Day? - MedicineNet
The average person sweats between 0.5-2 liters an hour during physical activity. But according to some studies, people may lose a minimum of 3 liters a day.Influencing Factors · Is It Normal
[35]
What Is Sweat & Why Do We Sweat? - Cleveland Clinic
Aug 15, 2024 · Acetylcholine is responsible for triggering most of your body's sweat production. But other neurotransmitters, including epinephrine and ...Anatomy · What's Sweat Made Of? · Conditions And Disorders
[36]
PAI1 inhibits the pathogenesis of primary focal hyperhidrosis ... - NIH
Primary focal hyperhidrosis (PFH) may be attributed to the up-regulation of the cholinergic receptor nicotinic alpha 1 subunit (CHRNA1) in eccrine glands.
[37]
Diaphoresis: What Is It, Causes, Signs, and More | Osmosis
Jan 6, 2025 · Menopause can cause episodes of excessive sweating, commonly known as “hot flashes.” This occurs as a result of hormonal changes, specifically ...
[38]
Infrared thermography in the diagnosis of palmar hyperhidrosis
Thermal imaging is a simple, noninvasive, and objective tool for the diagnosis of hyperhidrosis. It has potential utility in monitoring the effect of the ...Missing: gland | Show results with:gland
[39]
Diagnosis and qualitative identification of hyperhidrosis - Nawrocki
A threshold for axillary HH was determined to be >100 mg/5 minutes and >50 mg/5 minutes of sweat per axillae for men and women, respectively, or >50 mg/1 minute ...
[40]
Primary palmar hyperhidrosis locus maps to 14q11.2-q13 - PubMed
It is characterized by excessive perspiration of the eccrine sweat gland in the palm, sole, and the axilla.
[41]
Hyperhidrosis: Background, Pathophysiology, Etiology
Jul 1, 2024 · In its localized form, hyperhidrosis may result from a disruption followed by abnormal regeneration of sympathetic nerves or a localized ...Missing: CNS | Show results with:CNS<|separator|>
[42]
Pathophysiology of Excessive Sweating | Official Site
If there is generalized sympathetic overactivity in primary hyperhidrosis, catecholamine levels in patients could be predicted to be elevated. However, a ...Missing: neural factors
[43]
Hyperhidrosis - Symptoms, diagnosis and treatment
Classified as primary and of unknown cause (idiopathic), or secondary due to an underlying condition (usually an infectious, endocrine, or neurologic disorder).Missing: malignancies studies
[44]
Hyperhidrosis: disease aetiology, classification and management in ...
May 9, 2022 · Hyperhidrosis is a disorder of sweat glands characterized by overproduction of sweat, which is inadequate to the thermoregulatory needs of the body system.Hyperhidrosis Epidemiology · Hyperhidrosis... · Hyperhidrosis Diagnosis
[45]
Drug-Induced Hyperhidrosis: Mechanisms, diagnosis, and ...
Aug 21, 2025 · Many medications can induce secondary hyperhidrosis through various mechanisms, including effects on the autonomic nervous system, disruption of ...Missing: neurologic malignancies studies
[46]
Hyperhidrosis after COVID-19 infection | Archives of Dermatological ...
Feb 22, 2025 · Hyperhidrosis, characterized by excessive sweating, is rarely reported as a sequela of COVID-19 infection and can interfere with activities of daily living.
[47]
Hyperhidrosis Clinical Presentation: History, Physical Examination ...
Jul 1, 2024 · Essential hyperhidrosis is a dermatologic and neurologic disorder characterized by excessive sweating of the eccrine sweat glands.Missing: assessment | Show results with:assessment
[48]
Hyperhidrosis and bromhidrosis – aassessment and management
This article details an approach to the assessment and management of hyperhidrosis and bromhidrosis, and outlines current treatment options.Missing: hyperactivity biopsy
[49]
Hyperhidrosis: assessment and management in general practice - NIH
This clinical practice article describes how GPs can comprehensively assess and manage patients presenting with excessive sweating. ... The validated HDSS enables ...
[50]
recommendations of the Canadian Hyperhidrosis Advisory Committee
The Hyperhidrosis Disease Severity Scale (HDSS) provides a qualitative measure that allows tailoring of treatment. Mild axillary, palmar, and plantar ...
[51]
Diagnosis Guidelines - International Hyperhidrosis Society
The paper is then weighed and the rate of sweat production is calculated in mg/min. Sweating rates in normal individuals and in patients with hyperhidrosis are ...
[52]
Hyperhidrosis - Diagnosis and treatment - Mayo Clinic
Oct 25, 2024 · Diagnosis. Diagnosing hyperhidrosis may start with your health care provider asking about your medical history and symptoms.
[53]
Focal hyperhidrosis: diagnosis and management - PMC - NIH
Jan 4, 2005 · It usually peaks in the second or third decade of life and manifests as bilateral excessive sweat production confined to the armpits, soles of ...Diagnosis And Clinical... · Box 2 · TreatmentMissing: characteristics | Show results with:characteristics<|control11|><|separator|>
[54]
Hyperhidrosis | Northwestern Medicine
Diagnostic tests may include: Paper test: Special paper may be used to absorb the sweat and be weighed, determining the amount of sweating that is occurring.Hyperhidrosis · Diagnoses · TreatmentMissing: reliable sources
[55]
Thermoregulatory Sweat Test | Clinical Neurophysiology
The thermoregulatory sweat test (TST) consists of giving a controlled heat and humidity stimulus to produce a generalized sweat response.
[56]
Excessive Sweating (Hyperhidrosis) | University of Miami Health ...
such as an iodine-starch test, thermoregulatory sweat test, or a skin conductance test — to pinpoint the areas of ...
[57]
The New Age of Sudomotor Function Testing: A Sensitive ... - Frontiers
Sudorimetry technology has evolved dramatically, as a rapid, non-invasive, robust, and accurate biomarker for small fibers that can easily be integrated ...
[58]
Infrared thermography in the diagnosis of palmar hyperhidrosis
Thermal imaging is a simple, noninvasive, and objective tool for the diagnosis of hyperhidrosis. It has potential utility in monitoring the effect of the ...
[59]
The New Diagnostic Method for Hyperhidrosis: Digital Infrared ...
Digital infrared Thermographic Imaging(DITI) can show a thermal difference very clearly. We have used DITI not only for the diagnosis, but for planning of the ...
[60]
Studies on topical antiperspirant control of axillary hyperhidrosis
The hypothesis is presented that metallic antiperspirants act by reflux entrance into the terminal intraepidermal eccrine duct, slowly combining with the ...
[61]
Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and ...
Primary or essential hyperhidrosis is a disorder characterized by excessive, chronic, sweating acquired during rest, unrelated to the need of heat loss of the ...
[62]
Axillary hyperhidrosis: antiperspirant efficacy & tolerability
Treatment of axillary hyperhidrosis with aluminium chloride is an effective, safe and inexpensive treatment modality.
[63]
Iontophoresis - International Hyperhidrosis Society | Official Site
In a third study, the combination of 0.01% glycopyrrolate and 2% aluminum chloride was delivered by iontophoresis to patients with palmar hyperhidrosis.[129] ...
[64]
Efficacy of iontophoresis with glycopyrronium bromide for treatment ...
Aug 3, 2011 · Iontophoresis using glycopyrronium bromide is an effective and well-tolerated treatment for primary palmar hyperhidrosis.
[65]
The treatment of palmar hyperhidrosis - a systematic review - PubMed
Oct 15, 2021 · One study looking at the use of iontophoresis reported 81% improvement in patients' symptoms. One randomized, double-blind, trial looked at the ...
[66]
Hyperhidrosis: A Review of Recent Advances in Treatment ... - NIH
Nov 3, 2022 · ... sweat gland duct lumen [37]. Lifestyle modifications include avoiding HH triggers such as spicy foods, alcohol, crowded areas, and emotional ...
[67]
[PDF] 217347s000lbl.pdf - accessdata.fda.gov
Jun 19, 2024 · See full prescribing information for SOFDRA. SOFDRA (sofpironium) topical gel, 12.45%. Initial U.S. Approval: 2024. INDICATIONS AND USAGE.
[68]
a novel solution in the battle against primary axillary hyperhidrosis
Recently, on 18 June 2024, 12.45% sofpironium bromide (SB), an anticholinergic drug optimized through retro-metabolic design, received FDA approval for ...
[69]
Current and Emerging Medical Therapies for Primary Hyperhidrosis
Oct 27, 2016 · Hyperhidrosis is defined as the production of sweat beyond what is physiologically necessary to maintain thermal homeostasis.Missing: definition | Show results with:definition
[70]
Oxybutynin for the Treatment of Primary Hyperhidrosis - NIH
Dry mouth, headache, constipation, and urinary retention are relatively minor side effects seen with oxybutynin, particularly when the daily dose exceeds 15 mg ...
[71]
Use of Systemic Therapies to Manage Focal Hyperhidrosis - PMC
The most common side effect is dry mouth due to inhibition of salivary glands. There are many potential side effects (See Table 1), and concurrent use with ...
[72]
Review of Oral Anticholinergics in the Treatment of Palmoplantar ...
Dry mouth is experienced by 70%–100% of the patients treated with oxybutynin for HH.[70] Other adverse events observed include constipation in up to 31% of ...
[73]
Botulinum Toxin-loaded Detachable Dissolvable Microneedles ... - NIH
Intradermal axillary botulinum toxin injection is an effective treatment, with varying doses of onabotulinumtoxin A from 50-100 units in each armpit.
[74]
Treatment of hyperhidrosis with Botox (onabotulinumtoxinA)
The US Food and Drug Administration approved the use of onabotulinumtoxinA for treatment of primary axillary hyperhidrosis in 2004.
[75]
Duration of efficacy increases with the repetition of botulinum toxin A ...
The median duration of efficacy for the first injection was 5.5 months, whereas that for the last injection was 8.5 months. The difference between these 2 ...Missing: cost | Show results with:cost
[76]
Botox for Sweating: How It Works, Cost, Targeted Areas, and Risks
Mar 23, 2022 · The typical cost for both underarms can be about $1,000. Some insurance companies cover all or part of the cost for people with hyperhidrosis.
[77]
Clinical Evaluation of a Microwave Device for Treating Axillary ... - NIH
Mar 27, 2012 · At the 12-month follow-up visit, 90.3% had HDSS scores of 1 or 2, 90.3% had at least a 50% reduction in axillary sweat from baseline, and 85.2% ...
[78]
A novel modality using microwave technology for the treatment ... - NIH
The average gravimetric sweat reduction for patients treated with MiraDry (Miramar Labs Inc) is reported to be 82% at 12 months and may explain why we were ...
[79]
Patient satisfaction after miraDry® treatment for axillary ... - NIH
Oct 15, 2024 · In their study from 2012, Hong et al. reported an average reduction in sweat production of 82% after two treatments. The most common side ...
[80]
Treatments in Development - International Hyperhidrosis Society
Lasers for Potential Treatment of Hyperhidrosis. At Massachusetts General Hospital in Boston, experts are looking at the use of image-guided lasers to ablate ...
[81]
Bibliometric Analysis in Hyperhidrosis: Recent Publication Trends ...
Skin Therapy Lett. Narrative review, Treatments, 19, 3.2. 37, Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind ...
[82]
Management Strategies Of Palmar Hyperhidrosis - PubMed Central
Oct 4, 2019 · Aluminum chloride-based antiperspirants are a well-established first-line option for all types of primary focal hyperhidrosis (HH), regardless ...
[83]
Interventions for hyperhidrosis - PMC - PubMed Central - NIH
In addition to active therapeutic interventions, patients are advised to make lifestyle modifications to avoid any triggers for their hyperhidrosis such as ...
[84]
Real sweating in a virtual stress environment: Investigation of the ...
Aug 2, 2022 · Mental stimuli [16] and stressful situations [17] can trigger hyperhidrotic flare-ups. The increased sensitivity of sweat centres located in the ...
[85]
Quality of life in patients with primary axillary hyperhidrosis before ...
... stress condition can be considered as a trigger factor for initiation or exacerbation of the disease.[1,3,4] The disease, through its negative impacts on ...
[86]
Evaluating the Efficacy of Endoscopic Thoracic Sympathectomy for ...
Associated hyperhidrosis was considered to be present in 34 percent of ETS patients, 34 percent of sertraline patients, and 50 percent of nontreated patients.
[87]
High-dose botulinum toxin type A therapy for axillary hyperhidrosis ...
The relapse rate within 12 months of treatment was 4 of 34 patients (11.8%). The longest relapse-free interval observed was 29 months. Twenty-two patients ...
[88]
Comparative Study of Efficacy and Safety of Botulinum Toxin a ... - NIH
The exact mechanisms of recurrent hyperhidrosis after intradermal injection of BtxA are unknown. It has been consistently shown that new nerve endings grow ...Missing: relapse | Show results with:relapse
[89]
data from a retrospective cohort of all causes of recurrent sweating
Jul 29, 2022 · Secondary hyperhidrosis relies on an underlying condition. Excessive sweating has been reported in association with numerous diseases, including ...Missing: categories | Show results with:categories
[90]
Cutaneous Fungal Infections in Patients Experiencing ...
Oct 29, 2022 · Preventative treatment is important as such infections can lead to harmful complications such as cellulitis and even osteomyelitis.
[91]
Association of Primary Hyperhidrosis with Depression and Anxiety
Primary hyperhidrosis has been associated with anxiety and depression, but the magnitude of the alleged association is largely unknown.Missing: complications suicidality
[92]
Hyperhidrosis in social anxiety disorder - ScienceDirect.com
Excessive sweating (hyperhidrosis) is an overlooked and potentially disabling symptom, which is often seen in social anxiety disorder (SAD).Missing: psychological complications suicidality
[93]
Hyperhidrosis Associated with Higher Anxiety, Depression, ADD
Mar 5, 2019 · “There were some who had said they had suicidal thoughts because their sweating was ruining their life.” The study included 500 patients ...
[94]
Incidence and Severity of Compensatory Hyperhidrosis Following ...
Jul 11, 2024 · The surgery resulted in complete cessation of palmar hyperhidrosis in all 50 patients with a 100% success rate. Among the 50 patients, those ...
[95]
The Impact of Hyperhidrosis on Quality of Life - NIH
Jan 9, 2023 · Hyperhidrosis is a condition of excessive sweating, which can have profound physical and mental effects. Hyperhidrosis is a significantly ...
[96]
Hyperhidrosis: prevalence and impact on quality of life - PMC - NIH
Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and ...
[97]
Primary hyperhidrosis: an updated review - PubMed
Jun 16, 2025 · Hyperhidrosis (HH) is a condition characterized by excessive sweating beyond the physiological needs of thermoregulation.Missing: 2024 | Show results with:2024
[98]
Hyperhidrosis Prevalence and Demographical Characteristics in ...
Apr 22, 2016 · The prevalence of primary hyperhidrosis is very similar in Shanghai and in Vancouver, at 14.5% and 12.3% respectively.
[99]
Hyperhidrosis Epidemiology Forecast 2025-2034 - Market Research
May 13, 2025 · It is particularly prevalent among younger individuals, with 8.8% of people aged 18 to 39 affected. Epidemiological projections suggest that ...
[100]
Global research trends and hotspots of hyperhidrosis: a bibliometric ...
Apr 22, 2025 · This study aims to provide a detailed analysis of research trends and key areas of interest in hyperhidrosis over the last 16 years using bibliometric methods.Missing: GWAS receptor variants<|control11|><|separator|>
[101]
Sweating - Southeastern Skin
... 40% of patients with this condition seek medical advice. In ... treatment of severe underarm sweating, a condition called primary axillary hyperhidrosis.
[102]
Hyperhidrosis Prevalence and Demographical Characteristics in ...
The prevalence of primary hyperhidrosis is very similar in Shanghai and in Vancouver, at 14.5% and 12.3% respectively.
[103]
'Excessive sweating is not a feminine thing': A qualitative study ... - NIH
Jul 15, 2021 · Primary hyperhidrosis, excessive focal sweating is a common disease equally affecting men and women. Women tend to seek care more often and ...
[104]
Hyperhidrosis prevalence and its impact on population - Hasimoto
Jun 12, 2019 · The prevalence of hyperhidrosis found in the articles ranged from 0.072% to 16.3% (Table 1). As to the places of publishing, seven articles were ...Missing: tropical variation<|control11|><|separator|>
[105]
Palmar hyperhidrosis: evidence of genetic transmission - PubMed
Results: Thirty-two of 49 (65%) reported a positive family history in our hyperhidrosis group, and 0% reported a positive family history in our control group. A ...
[106]
[PDF] Palmar hyperhidrosis: Evidence of genetic - transmission
Dec 27, 2001 · Results: Thirty-two of 49 (65%) reported a positive family history in our hyperhidrosis group, and 0% reported a pos- itive family history in ...
[107]
Hyperhidrosis | Johns Hopkins Medicine
Hyperhidrosis is excessive sweating, which means sweating more than normal. People with hyperhidrosis report feelings of social isolation and withdrawal from ...